These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12789683)

  • 1. Rivastigmine in prevention of delirium in a 65 years old man with Parkinson's disease.
    Dautzenberg PL; Wouters CJ; Oudejans I; Samson MM
    Int J Geriatr Psychiatry; 2003 Jun; 18(6):555-6. PubMed ID: 12789683
    [No Abstract]   [Full Text] [Related]  

  • 2. Delirium in elderly hospitalised patients: protective effects of chronic rivastigmine usage.
    Dautzenberg PL; Mulder LJ; Olde Rikkert MG; Wouters CJ; Loonen AJ
    Int J Geriatr Psychiatry; 2004 Jul; 19(7):641-4. PubMed ID: 15254920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
    Kalisvaart CJ; Boelaarts L; de Jonghe JF; Hovinga IM; Kat MG
    Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1501-4. PubMed ID: 15481575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivastigmine in the treatment of alcohol-induced persisting dementia.
    Gibson RC; Barnaby L
    West Indian Med J; 2003 Mar; 52(1):59-61. PubMed ID: 12806761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.
    Bullock R; Cameron A
    Curr Med Res Opin; 2002; 18(5):258-64. PubMed ID: 12240787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor.
    Fischer P
    J Clin Psychopharmacol; 2001 Feb; 21(1):118. PubMed ID: 11199939
    [No Abstract]   [Full Text] [Related]  

  • 7. Rivastigmine treatment of Othello syndrome and post-ECT delirium in a patient with Parkinson's disease.
    Scicutella A
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e90. PubMed ID: 25716514
    [No Abstract]   [Full Text] [Related]  

  • 8. Rivastigmine (Exelon) for dementia in patients with Parkinson's disease.
    Giladi N; Shabtai H; Gurevich T; Benbunan B; Anca M; Korczyn AD
    Acta Neurol Scand; 2003 Nov; 108(5):368-73. PubMed ID: 14616309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
    Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
    Moerkens RM; Dhondt AD
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712654
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
    Mol JA
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712655
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
    Burn D; Emre M; McKeith I; De Deyn PP; Aarsland D; Hsu C; Lane R
    Mov Disord; 2006 Nov; 21(11):1899-907. PubMed ID: 16960863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients.
    Fogelson N; Kogan E; Korczyn AD; Giladi N; Shabtai H; Neufeld MY
    Acta Neurol Scand; 2003 Apr; 107(4):252-5. PubMed ID: 12675697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rivastigmine against dementia in Parkinson disease?].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2007 Nov; 127(22):2973; author reply 2973-4. PubMed ID: 18026256
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinesterase inhibitors and delirium after cardiac surgery.
    Yazigi A; Madi-Jebara S; Haddad F; Hayek G
    Crit Care Med; 2010 Apr; 38(4):1231. PubMed ID: 20335721
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of delirium following cardiac surgery.
    Groen JA; Banayan D; Gupta S; Xu S; Bhalerao S
    J Card Surg; 2012 Sep; 27(5):589-93. PubMed ID: 22978835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study.
    Poewe W; Wolters E; Emre M; Onofrj M; Hsu C; Tekin S; Lane R;
    Mov Disord; 2006 Apr; 21(4):456-61. PubMed ID: 16229010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivastigmine: new indication. Dementia and Parkinson's disease: no thank you!
    Prescrire Int; 2007 Apr; 16(88):66. PubMed ID: 17458048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivastigmine for dementia associated with Parkinson's disease.
    Harada CN; Shega JW; Sachs GA
    N Engl J Med; 2005 Mar; 352(13):1387; author reply 1387. PubMed ID: 15800242
    [No Abstract]   [Full Text] [Related]  

  • 20. Rivastigmine in Parkinson's disease dementia.
    Lalli S; Albanese A
    Expert Rev Neurother; 2008 Aug; 8(8):1181-8. PubMed ID: 18671661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.